To further investigate the potential molecular mechanism by which CT45A regulates breast cancer cell migration, we monitored the alteration of EMT markers, including N-cadherin and vimentin, two well-characterized mesenchymal markers, and E-cadherin, a well-known epithelial marker [35, 55]. The gene discussed is CDH2; the disease is breast cancer.